paeonol and Edema
paeonol has been researched along with Edema in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chao, QL; Chen, DQ; Fan, HY; Jin, X; Liu, YR; Qiu, F; Shang, CH; Wang, J; Xia, ZM; Zhao, F | 1 |
| Chae, HS; Choi, JG; Jang, HJ; Jeong, SI; Kang, OH; Kim, JH; Kim, MS; Kwon, DY; Lee, YS; Oh, YC | 1 |
| Ao, G; Cao, Q; Chen, D; Cui, J; Wu, D | 1 |
Other Studies
3 other study(ies) available for paeonol and Edema
| Article | Year |
|---|---|
Anti-inflammatory and Anti-oxidative Activities of Paeonol and Its Metabolites Through Blocking MAPK/ERK/p38 Signaling Pathway.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Antioxidants; Carrageenan; Cell Line; Colitis; Cyclooxygenase 2; Dextran Sulfate; Edema; Extracellular Signal-Regulated MAP Kinases; Hindlimb; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells.
Topics: Acetophenones; Analgesics; Animals; Anti-Inflammatory Agents; Cell Survival; Cyclooxygenase 2; Cynanchum; Dinoprostone; Edema; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Pain; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Sprague-Dawley | 2009 |
In vitro and in vivo evaluation of ibuprofen-paeonol conjugate.
Topics: Acetic Acid; Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cytoprotection; Dinoprostone; Disease Models, Animal; Drug Combinations; Drug Compounding; Drug Stability; Edema; Esterification; Gastric Mucosa; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Injections, Intravenous; Intestinal Absorption; Magnetic Resonance Spectroscopy; Malondialdehyde; Mice; Nitric Oxide; Pain; Particle Size; Protective Agents; Rats; Stomach; Technology, Pharmaceutical; Xylenes | 2011 |